Mouse Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Pre-Fusion glycoprotein F0)

Customer Reviews
Cat. No. / Size
Price
Qty
RAS-T174-96tests
$770.00
ETA of in-stock products:2 business days

Product Details

  • Materials Provided

    ID
    Components
    Size
    RAS174-C01
    Pre-coated RSV-Pre-Fusion glycoprotein F0 Microplate
    1 plate
    RAS174-C02
    RSV-F0 Antibody Positive Control
    100 μL
    RAS174-C03
    RSV-F0 Antibody Negative Control
    100 μL
    RAS174-C04
    HRP-Conjugated Antibody
    50 μL
    RAS174-C05
    10 x Washing Buffer
    50 mL
    RAS174-C06
    Dilution Buffer
    50 mL
    RAS174-C07
    Substrate Solution
    12 mL
    RAS174-C08
    Stop Solution
    7 mL

  • Product Overview

    Mouse Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Pre-Fusion glycoprotein F0) is based on the indirect-ELISA method and is used to measure the Anti-RSV-F0 Antibody IgG (Pre-Fusion glycoprotein F0) titer in mouse serum. The kit is designed to provide a reliable solution for evaluating the immunogenicity during the preclinical stage of RSV vaccine development.

  • Storage

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Customer Reviews
Writing Reviews

FAQ

  • Product

    What do “pre” and “post” refer to in the names of viral proteins?

    In virology, “pre” refers to the conformation of a viral surface glycoprotein before fusion with the host cell membrane, while “post” refers to the conformation after membrane fusion and entry into the host cell. Both are naturally occurring states in the viral life cycle. Because the “pre” conformation represents a critical stage before viral entry, antibodies designed against this state often exhibit stronger neutralizing activity and are therefore more effective in preventing infection.

Recent Advances

 
Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Customer Reviews
  • FAQ
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8